Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
出版年份 2022 全文链接
标题
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 24, Pages 15751
出版商
MDPI AG
发表日期
2022-12-12
DOI
10.3390/ijms232415751
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
- (2022) Chanju Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of anti‐PD‐L1 antibody with peptide MEL‐dKLA targeting M2 tumor‐associated macrophages suppresses breast cancer metastasis
- (2022) Chanju Lee et al. Cancer Communications
- Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
- (2022) Ik-Hwan Han et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor-associated macrophages promote epithelial–mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling
- (2022) Xiangzhou Chen et al. Cell Communication and Signaling
- PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation
- (2022) Hyeran Seo et al. DRUG DELIVERY
- Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
- (2021) Yan Lv et al. OncoTargets and Therapy
- Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy
- (2021) Tenzin Tender et al. MEDICAL ONCOLOGY
- Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer
- (2021) Anita K. Mehta et al. Frontiers in Immunology
- Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
- (2021) Huimei Yi et al. Frontiers in Oncology
- Nanoparticles Targeting Innate Immune Cells in Tumor Microenvironment
- (2021) Hochung Jang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
- (2020) K.G.K. Deepak et al. PHARMACOLOGICAL RESEARCH
- Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer
- (2020) Maria Gagliardi et al. Scientific Reports
- Targeting tumor-associated macrophages in head and neck squamous cell carcinoma
- (2020) Bolei Li et al. ORAL ONCOLOGY
- Triple‑negative breast cancer therapy: Current and future perspectives (Review)
- (2020) Kwang‑Ai Won et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting tumor‑associated macrophages in the tumor microenvironment (Review)
- (2020) Kaiwen Zhou et al. Oncology Letters
- Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
- (2020) Irina Larionova et al. Frontiers in Oncology
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
- (2020) Javier Cortes et al. LANCET
- Targeting Tumor-Associated Macrophages in Cancer
- (2019) Paulina Pathria et al. TRENDS IN IMMUNOLOGY
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ
- (2019) Chang Liu et al. IMMUNITY
- Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin
- (2019) Sara Pandidan et al. Scientific Reports
- Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide
- (2019) Chanju Lee et al. Journal for ImmunoTherapy of Cancer
- Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach
- (2019) Yacine Bareche et al. JNCI-Journal of the National Cancer Institute
- The membrane effects of melittin on gastric and colorectal cancer
- (2019) Caroline Soliman et al. PLoS One
- 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment
- (2018) Sofia P. Rebelo et al. BIOMATERIALS
- Breast cancer lung metastasis: Molecular biology and therapeutic implications
- (2018) Liting Jin et al. CANCER BIOLOGY & THERAPY
- Anti-Tumor Effects of Melittin and Its Potential Applications in Clinic
- (2018) Can Lyu et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular details on the intermediate states of melittin action on a cell membrane
- (2018) Jiaojiao Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Tumor-associated macrophages in breast cancer: Innocent bystander or important player?
- (2018) Si-Qi Qiu et al. CANCER TREATMENT REVIEWS
- Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer
- (2018) Jonas Steenbrugge et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Protein PEGylation for cancer therapy: bench to bedside
- (2018) Vijayalaxmi Gupta et al. Journal of Cell Communication and Signaling
- Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model
- (2017) Chanju Lee et al. Oncotarget
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer
- (2015) K. E. Hew et al. CLINICAL CANCER RESEARCH
- What is the future of PEGylated therapies?
- (2015) Magdalena Swierczewska et al. EXPERT OPINION ON EMERGING DRUGS
- Site-Specific PEGylation of Therapeutic Proteins
- (2015) Jonathan Dozier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway
- (2015) Sangmin Kim et al. Oncotarget
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- High-Infiltration of Tumor-Associated Macrophages Predicts Unfavorable Clinical Outcome for Node-Negative Breast Cancer
- (2013) Yue Zhang et al. PLoS One
- The dynamics of melittin-induced membrane permeability
- (2012) Gašper Kokot et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Differentiation and gene expression profile of tumor-associated macrophages
- (2012) Astrid Schmieder et al. SEMINARS IN CANCER BIOLOGY
- Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression
- (2011) Rui Wang et al. LUNG CANCER
- Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
- (2011) L. Agemy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway
- (2011) Miran Jo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Cytolytic peptide nanoparticles (‘NanoBees’) for cancer therapy
- (2011) Hua Pan et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Emerging PEGylated drugs
- (2009) Jung Seok Kang et al. EXPERT OPINION ON EMERGING DRUGS
- Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
- (2009) Neelesh R. Soman et al. JOURNAL OF CLINICAL INVESTIGATION
- On the Mechanism of Pore Formation by Melittin
- (2008) Geert van den Bogaart et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started